Journal: The Journal of Biological Chemistry
Article Title: Discovery of small molecules and a druggable groove that regulate DNA binding and release of the AP-1 transcription factor ΔFOSB
doi: 10.1016/j.jbc.2025.111080
Figure Lengend Snippet: Effect of JPC0661 on ΔFOSB binding in dorsal hippocampus in vivo . APP mice were infused via osmotic minipumps into the dorsal hippocampus for 3 days with vehicle (“Control”) or JPC0661 (“Treatment”). Subsequently, genome-wide ΔFOSB binding was quantified with CUT&RUN sequencing performed on nuclei isolated from unilateral dorsal hippocampus tissue of individual vehicle- or JPC0661-treated mice. A , total number of ΔFOSB-bound peaks in the dorsal hippocampus of male and female APP mice receiving vehicle versus JPC0661. B , width of ΔFOSB-bound peaks from samples in ( A ). Data for ( A ) and ( B ) below are shown as mean ± SEM (n = 5 per group); ∗ p < 0.05. No sex differences were observed for ( A ) and ( B ). C , genomic distribution of ΔFOSB peaks in the dorsal hippocampus under vehicle and JPC0661 conditions, showing the percentage of peaks at the promoter, intronic, or intergenic regions. D , heatmaps showing ΔFOSB binding intensity centered around the transcription start sites (TSSs) in APP mice under vehicle ( left ) and JPC0661 ( right ) conditions, showing reduced number and amplitudes in the latter condition. E , motif analysis showing that the vast majority of ΔFOSB peaks are bound to sequences that contain AP-1 consensus sequences (TGA C/G TCA). F , number of unique genes with ΔFOSB peaks bound to gene promoter regions in APP mice treated with vehicle or JPC0661, analyzed via Venn diagrams, indicating that the predominant effect of JPC0661 is to deplete peaks seen also under vehicle-treated conditions. G , Gene Ontology (GO) enrichment analysis of genes associated with ΔFOSB promoter–binding peaks in vehicle-treated (Control_Promoter, red ) and JPC0661-treated (JPC0661_Promoter, green ) conditions. Dot size represents the significance (-log 10 of the adjusted p value), and “Odds.Ratio” indicates pathway enrichment. H , example of ΔFOSB binding at the promoter region of Creb1 . Shown are samples from the dorsal hippocampus of APP mice treated with vehicle ( top track in sky blue ) or treated with JPC0661 ( middle track in gold-green ) using an anti-ΔFOSB-antibody for CUT&RUN sequencing versus using an IgG antibody as a control for nonspecific binding ( bottom track in dark blue ; subtracted background). I , number of unique genes with ΔFOSB peaks bound to the distal intergenic regions in APP mice treated with vehicle or JPC0661, analyzed via Venn diagrams, indicating that the predominant effect of JPC0661 is to deplete peaks seen under vehicle-treated conditions. J , GO terms for the unique genes bound by ΔFOSB at intergenic regions, as described also in ( G ). K , example of ΔFOSB binding at a distal intergenic/putative enhancer region of Fos , as described in ( H ). AP-1, activator protein 1; APP, amyloid precursor protein; GO, Gene Ontology; IgG, immunoglobulin G.
Article Snippet: One subseries was stained for ΔFOSB with the avidin–biotin diaminobenzidine method, using rabbit anti-ΔFOSB (1:5000 dilution; Cell Signaling, D3S8R) as the primary antibody, biotinylated goat anti-rabbit (1:200 dilution; Vector, BA-1000) as the secondary antibody, and diaminobenzidine as the chromogen.
Techniques: Binding Assay, In Vivo, Control, Genome Wide, Sequencing, Isolation